Endoc Biotech Private Limited

Endoc Biotech Private Limited - pharma in Rajkot, Gujarat, India. FY 2026 financials and compliance.
CIN U24304GJ2020PTC112449 Incorporated 31 January 2020 ROC Ahmedabad HQ Rajkot, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
-
Latest filing
EBITDA · FY 2024
*****
▲ 0.00% YoY
Net profit · FY 2024
*****
In full report
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹7.1 Cr
Issued & subscribed
Open charges
₹36 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2024
Balance sheet date

About Endoc Biotech Private Limited

Data last updated: 08 January 2026

Endoc Biotech Private Limited is a private limited company based in Rajkot, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 January 2020, the company has been in operation for over 6 years.

Registered with ROC Ahmedabad under CIN U24304GJ2020PTC112449.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹7.1 Cr. It is led by directors including Suresh Devjibhai Sorathiya and Jigneshkumar Devrajbhai Akbari.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: D – 601 6Th Floor Imperial Heights Opp. Big Bazaar 150 Feet Ring Road, Rajkot, Gujarat, India – 360005.

As per MCA filings, the company has open charges of ₹36 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website endocbiotech.com.

Company Details of Endoc Biotech Private Limited
CIN U24304GJ2020PTC112449
Registration Number 112449
Incorporation Date 31 January 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Suresh Devjibhai Sorathiya Director Jigneshkumar Devrajbhai Akbari Director Ghanashyam Govindbhai Harsoda Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    endocbiotech.com
  • Social Media
    **************
  • Registered Address
    D – 601 6Th Floor Imperial Heights Opp. Big Bazaar 150 Feet Ring Road, Rajkot, Gujarat, India – 360005
  • Industry
    Pharma, Drug Formulation & Development
Company report
Endoc Biotech Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Endoc Biotech Private Limited report

Financials, compliance, directors, charges, ownership and filings for Endoc Biotech Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Endoc Biotech Private Limited

Endoc Biotech Private Limited is audited by CA Harshil Rajeshbhai Hakani for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
CA Harshil Rajeshbhai Hakani blur-value blur-value blur-value

Board of Directors of Endoc Biotech Private Limited

Endoc Biotech Private Limited is governed by 4 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Suresh Devjibhai Sorathiya
Also directs: Skywin Spinning Private Limited, Earth Spintex Private Limited, Snj Lifecare Private Limited and 5 more
Director 31 Jan 2020 6 Years 5 Months Current
Jigneshkumar Devrajbhai Akbari
Also directs: Snj Lifecare Private Limited, Snj Labs Private Limited, Pmech Engitech Private Limited and 1 more
Director 31 Jan 2020 6 Years 5 Months Current
Ghanashyam Govindbhai Harsoda
Also directs: Nira Life Sciences Private Limited
Director 31 Jan 2020 6 Years 5 Months Current
Vinodkumar Kalabhai Asodariya
Also directs: Flotech Sales Llp, Harvin Developer Llp, Flotech Engineering Private Limited and 1 more
Director 31 Jan 2020 6 Years 5 Months Current
View all directors

Financials of Endoc Biotech Private Limited FY 2024 filings available

Endoc Biotech Private Limited reported revenue of ₹- (up ) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
EBITDA
*****
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Endoc Biotech Private Limited

As of FY 2023, Endoc Biotech Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Endoc Biotech Private Limited

Open charges
₹36 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Hdfc Bank Limited₹36.00 Cr
Latest charge details
DateLenderAmountStatus
24 Feb 2023 Hdfc Bank Limited ₹36 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Endoc Biotech Private Limited

View historical data on people associated with Endoc Biotech Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Endoc Biotech Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Endoc Biotech Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Endoc Biotech Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Endoc Biotech Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Endoc Biotech Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Endoc Biotech Private Limited

MSME Payment Delays by Endoc Biotech Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Endoc Biotech Private Limited

Subsidiaries & Group Companies of Endoc Biotech Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Endoc Biotech Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Endoc Biotech Private Limited

MCA Filings & Documents of Endoc Biotech Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Endoc Biotech Private Limited

Activity
30 Sep 2024
Endoc Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Endoc Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
25 May 2023
A charge with Hdfc Bank Limited of Rs. 36.00 Cr registered on 24 Feb 2023 with Charge ID 100683772 was modified on 25 May 2023.
Charges
24 Feb 2023
A charge with Hdfc Bank Limited amounted to Rs. 36.00 Cr with Charge ID 100683772 was registered on 24 Feb 2023.
Directors
31 Jan 2020
Suresh Devjibhai Sorathiya was appointed as a Director on 31 Jan 2020 & has been associated with this company since 6 years 5 months.
Directors
31 Jan 2020
Jigneshkumar Devrajbhai Akbari was appointed as a Director on 31 Jan 2020 & has been associated with this company since 6 years 5 months.

Frequently Asked Questions about Endoc Biotech Private Limited

Endoc Biotech Private Limited is an active private limited company in the pharma sector based in Rajkot, Gujarat, India. It was incorporated on 31 January 2020 (6+ years old) and is registered under CIN U24304GJ2020PTC112449.

The current directors of Endoc Biotech Private Limited are:

The primary industry of Endoc Biotech Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Endoc Biotech Private Limited can be reached at the registered office: D – 601 6Th Floor Imperial Heights Opp. Big Bazaar 150 Feet Ring Road, Rajkot, Gujarat, India – 360005, or through the website endocbiotech.com.

The authorised capital is ₹15 Cr, and the paid-up capital is ₹7.1 Cr.

The company has its registered office at D – 601 6Th Floor Imperial Heights Opp. Big Bazaar 150 Feet Ring Road, Rajkot, Gujarat, India – 360005.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available